iDealTherapy™
Clinical Support Services, Inc. (CSS) has developed iDealTherapy™, a program that assesses a patient’s current drug therapy and determines if a more ideal medication may be a better value for the condition being treated.
Unlike many retrospective Drug Utilization Review (DUR) processes, iDealTherapy incorporates current clinical information provided by the prescriber with pharmacy claims data to evaluate drug therapy utilization.
The benefits of this enhanced process are:
-
Clinically-Appropriate RecommendationsAll recommendations made to physicians have already been confirmed as clinically appropriate using the prescriber’s own clinical information
-
Prescriber-Authorized RecommendationsNo drug therapy changes are made without approval by the prescriber, enhancing patient confidence in the process and eliminating disruption at point-of-service (e.g., pre-authorizations, etc.)
-
Targeted RecommendationsRecommendations that are not clinically appropriate are not sent to prescribers. Therefore, prescribers will not be frustrated by a process that appears to generate random recommendations
-
Enhanced Response RateThe combination of targeted, clinically-appropriate recommendations enhances the prescriber's response to recommendations. Our response rate to clinical therapy changes varies by therapy, but averages more than 50 percent.
-
Population InsightObtaining clinical information as a part of the clinical iDealTherapy process allows employers to gain advanced insight into the utilization habits of its employees. This data can be used to deploy employee health and wellness initiatives to further enhance worksite wellness and performance.
-
Broad-Based Clinical Programs
- Gastrointestinal Program: Proton Pump Inhibitors and H2 Antagonists.
- Dyslipidemia Program: HMG Co-A Reductase Inhibitors.
- Cardiovascular Program: Angiotensin Receptor Blocking Agents.
- Osteoporosis Program: Bisphosphonates.
- Non-Steroidal Anti-Inflammatory Drug Program: COX 2 Antagonists.
- Rhinitis Program: Nasal Steroids and Non-sedating Antihistamines.